EGFL7 and gastric cancer: Similar as in miR-126 overexpressing cancerous GC, the AKT pathway was also repressed in EGFL7 KD cancerous GC (Figure 4F), further confirming that the effect of the miR-126/EGFL7 regulatory axis on cancerous GC is mediated by AKT pathway.